ATAI Life Sciences
ATAI
ATAI
101 hedge funds and large institutions have $88.2M invested in ATAI Life Sciences in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 97 → 101 (+4)
3.02% more ownership
Funds ownership: 13.46% → 16.48% (+3%)
Holders
101
Holding in Top 10
1
Calls
$997K
Puts
$824K
Top Buyers
| 1 | +$15M | |
| 2 | +$2.5M | |
| 3 | +$2.31M | |
| 4 |
BlackRock
New York
|
+$995K |
| 5 |
Morgan Stanley
New York
|
+$627K |
Top Sellers
| 1 | -$953K | |
| 2 | -$596K | |
| 3 | -$329K | |
| 4 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$299K |
| 5 |
GFI
Global Frontier Investments
Charleston,
South Carolina
|
-$244K |